-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Jounce Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2016 to Q4 2022.
- Jounce Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $117K, a 1850% increase year-over-year.
- Jounce Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2022 was $135K, a 800% increase year-over-year.
- Jounce Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $135K, a 800% increase from 2021.
- Jounce Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $15K, a 7.14% increase from 2020.
- Jounce Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2020 was $14K, a 69.6% decline from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)